Trial intelligence / Profile preview

Sodium Nitrite in Patients Undergoing CABG Surgery

NCT04001283Phase 2Unknown

Sponsor
University of East Anglia
Start
Jan 2013
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of sodium nitrite in coronary artery disease (CAD) (3 arms), sponsored by University of East Anglia. Primary endpoint: Metabolic protein expression in cardiac biopsies and vascular offcuts. Status: unknown.

02

Drugs

sodium nitrite
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT04001283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04001283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call